Two Sigma Investments LP Buys New Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Two Sigma Investments LP bought a new position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 45,293 shares of the company's stock, valued at approximately $334,000.

Other institutional investors have also made changes to their positions in the company. Dimensional Fund Advisors LP raised its holdings in LifeStance Health Group by 87.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company's stock worth $25,977,000 after acquiring an additional 1,643,390 shares during the period. Vanguard Group Inc. raised its holdings in shares of LifeStance Health Group by 7.9% in the fourth quarter. Vanguard Group Inc. now owns 10,689,396 shares of the company's stock valued at $78,781,000 after buying an additional 784,818 shares during the last quarter. First Trust Advisors LP acquired a new position in LifeStance Health Group during the 4th quarter worth $4,535,000. First Eagle Investment Management LLC boosted its stake in shares of LifeStance Health Group by 182.8% in the 4th quarter. First Eagle Investment Management LLC now owns 785,666 shares of the company's stock valued at $5,790,000 after purchasing an additional 507,826 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its holdings in LifeStance Health Group by 421.5% during the fourth quarter. Renaissance Technologies LLC now owns 612,800 shares of the company's stock worth $4,516,000 after buying an additional 495,300 shares during the last quarter. 85.50% of the stock is currently owned by institutional investors and hedge funds.

LifeStance Health Group Trading Down 3.0%

LFST stock traded down $0.16 during mid-day trading on Friday, reaching $5.26. The company's stock had a trading volume of 1,265,582 shares, compared to its average volume of 1,607,011. The business's 50 day moving average price is $6.14 and its 200 day moving average price is $7.02. LifeStance Health Group, Inc. has a 12 month low of $4.64 and a 12 month high of $8.61. The company has a market cap of $2.05 billion, a price-to-earnings ratio of -20.23 and a beta of 1.22. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19.

Analyst Upgrades and Downgrades

Several analysts have commented on LFST shares. KeyCorp began coverage on shares of LifeStance Health Group in a report on Tuesday, April 8th. They set an "overweight" rating and a $9.00 target price on the stock. Canaccord Genuity Group started coverage on shares of LifeStance Health Group in a research report on Thursday, April 3rd. They set a "buy" rating and a $8.00 price target on the stock. UBS Group upgraded shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 price target on the stock in a research report on Tuesday, May 27th. Finally, William Blair reiterated an "outperform" rating on shares of LifeStance Health Group in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $8.50.

Insider Activity at LifeStance Health Group

In other LifeStance Health Group news, insider Ujjwal Ramtekkar sold 16,000 shares of the business's stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $5.94, for a total value of $95,040.00. Following the sale, the insider now directly owns 113,435 shares in the company, valued at $673,803.90. The trade was a 12.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Lisa K. Miller sold 18,845 shares of the company's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $6.90, for a total transaction of $130,030.50. Following the sale, the insider now owns 339,810 shares in the company, valued at $2,344,689. The trade was a 5.25% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 34,859 shares of company stock valued at $225,169 in the last three months. Corporate insiders own 3.20% of the company's stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.